BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31371701)

  • 1. Plasma neurofilament light chain concentration is increased in anorexia nervosa.
    Nilsson IAK; Millischer V; Karrenbauer VD; Juréus A; Salehi AM; Norring C; von Hausswolff-Juhlin Y; Schalling M; Blennow K; Bulik CM; Zetterberg H; Landén M
    Transl Psychiatry; 2019 Aug; 9(1):180. PubMed ID: 31371701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury.
    Wentz E; Dobrescu SR; Dinkler L; Gillberg C; Gillberg C; Blennow K; Råstam M; Zetterberg H
    Eur Child Adolesc Psychiatry; 2021 Dec; 30(12):1907-1915. PubMed ID: 33040187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confounding effect of blood volume and body mass index on blood neurofilament light chain levels.
    Manouchehrinia A; Piehl F; Hillert J; Kuhle J; Alfredsson L; Olsson T; Kockum I
    Ann Clin Transl Neurol; 2020 Jan; 7(1):139-143. PubMed ID: 31893563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
    Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
    J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.
    Piehl F; Kockum I; Khademi M; Blennow K; Lycke J; Zetterberg H; Olsson T
    Mult Scler; 2018 Jul; 24(8):1046-1054. PubMed ID: 28627962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
    Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
    EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neurofilament light chain in behavioral variant frontotemporal dementia.
    Steinacker P; Anderl-Straub S; Diehl-Schmid J; Semler E; Uttner I; von Arnim CAF; Barthel H; Danek A; Fassbender K; Fliessbach K; Foerstl H; Grimmer T; Huppertz HJ; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Maler JM; Mayer B; Oeckl P; Prudlo J; Schneider A; Volk AE; Wiltfang J; Schroeter ML; Ludolph AC; Otto M;
    Neurology; 2018 Oct; 91(15):e1390-e1401. PubMed ID: 30209235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Andreasson U; Zetterberg H; Blennow K;
    JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neurofilament light chain as a prognostic marker in postanoxic encephalopathy.
    Disanto G; Prosperetti C; Gobbi C; Barro C; Michalak Z; Cassina T; Kuhle J; Casso G; Agazzi P
    Epilepsy Behav; 2019 Dec; 101(Pt B):106432. PubMed ID: 31375414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
    Zetterberg H; Skillbäck T; Mattsson N; Trojanowski JQ; Portelius E; Shaw LM; Weiner MW; Blennow K;
    JAMA Neurol; 2016 Jan; 73(1):60-7. PubMed ID: 26524180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery.
    Casanueva FF; Dieguez C; Popovic V; Peino R; Considine RV; Caro JF
    Biochem Mol Med; 1997 Apr; 60(2):116-20. PubMed ID: 9169091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
    Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leptin concentrations in patients with anorexia nervosa, bulimia nervosa and non-specific eating disorders correlate with the body mass index but are independent of the respective disease.
    Ferron F; Considine RV; Peino R; Lado IG; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):289-93. PubMed ID: 9156037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa.
    Otto B; Cuntz U; Fruehauf E; Wawarta R; Folwaczny C; Riepl RL; Heiman ML; Lehnert P; Fichter M; Tschöp M
    Eur J Endocrinol; 2001 Nov; 145(5):669-73. PubMed ID: 11720888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
    Chatterjee P; Zetterberg H; Goozee K; Lim CK; Jacobs KR; Ashton NJ; Hye A; Pedrini S; Sohrabi HR; Shah T; Asih PR; Dave P; Shen K; Taddei K; Lovejoy DB; Guillemin GJ; Blennow K; Martins RN
    J Neuroinflammation; 2019 Oct; 16(1):186. PubMed ID: 31601232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J
    Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of insulin, leptin and neuropeptide y by radioimmunoanalysis in patients with morbid obesity and anorexia nervosa after therapeutic intervention].
    Escobar L; Freire JM; Espinosa R; Pajares M; Girón JA; Vázquez JM; Chover A; Carrasco M; Ortero J; Gavilán I; Segura E; Aguilar M
    Rev Esp Med Nucl; 2002 Feb; 21(1):3-11. PubMed ID: 11820995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.